Search Within

Cristina R Antonescu

  1. "Ferdinando Rossi"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (1)
Groups
  1. Department of Pathology and Laboratory Medicine (17)
  2. GSK Faculty (17)
  3. Sloan Kettering Institute Postdocs (17)
  4. Tow Center for Developmental Oncology (TCDO) (17)
  5. Developmental Biology Program Faculty (15)
  6. Sloan Kettering Institute Faculty (15)

More Groups

People
  1. Ferdinando Rossi (17)
  2. Peter Besmer (15)
  3. Ronald DeMatteo (10)
  4. Shan Zeng (9)
  5. Adrian Seifert (7)
  6. Jennifer Loo (6)

More People

Years
  1. 2020 (1)
  2. 2018 (2)
  3. 2017 (3)
  4. 2015 (2)
  5. 2014 (2)
  6. 2013 (1)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (4)
  2. Cancer Research (3)
  3. Clinical Cancer Research (3)
  4. Cancer Discovery (1)
  5. Cancer Immunology Research (1)
  6. Journal of Experimental Medicine (1)

More Publications

Publishers
  1. American Association for Cancer Research (10)
  2. National Academy of Sciences (4)
  3. Nature Publishing Group (2)
  4. Rockefeller University Press (1)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor
    Journal Article

    Zhang, J. Q.; Bosbach, B.; Loo, J. K.; Vitiello, G. A.; Zeng, S.; Seifert, A. M.; Medina, B. D.; Param, N. J.; Maltbaek, J. H.; Rossi, F.; more...
    Oncogene (2020)

    Fulltext@MSK | Save
  • Macrophages and CD8(+) T cells mediate the antitumor efficacy of combined CD40 ligation and imatinib therapy in gastrointestinal stromal tumors
    Journal Article

    Zhang, J. Q.; Zeng, S.; Vitiello, G. A.; Seifert, A. M.; Medina, B. D.; Beckman, M. J.; Loo, J. K.; Santamaria-Barria, J.; Maltbaek, J. H.; Param, N. J.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Mitochondrial inhibition augments the efficacy of imatinib by resetting the metabolic phenotype of gastrointestinal stromal tumor
    Journal Article

    Vitiello, G. A.; Medina, B. D.; Zeng, S.; Bowler, T. G.; Zhang, J. Q.; Loo, J. K.; Param, N. J.; Liu, M.; Moral, A. J.; Zhao, J. N.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor
    Journal Article

    Bosbach, B.; Rossi, F.; Yozgat, Y.; Loo, J.; Zhang, J. Q.; Berrozpe, G.; Warpinski, K.; Ehlers, I.; Veach, D.; Kwok, A.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2017)

    Fulltext@MSK | Save
  • Wnt/β-catenin signaling contributes to tumor malignancy and is targetable in gastrointestinal stromal tumor
    Journal Article

    Zeng, S.; Seifert, A. M.; Zhang, J. Q.; Cavnar, M. J.; Kim, T. S.; Balachandran, V. P.; Santamaria-Barria, J. A.; Cohen, N. A.; Beckman, M. J.; Medina, B. D.; more...
    Molecular Cancer Therapeutics (2017)

    Fulltext@MSK | Save
  • PD-1/PD-L1 blockade enhances T-cell activity and antitumor efficacy of imatinib in gastrointestinal stromal tumors
    Journal Article

    Seifert, A. M.; Zeng, S.; Zhang, J. Q.; Kim, T. S.; Cohen, N. A.; Beckman, M. J.; Medina, B. D.; Maltbaek, J. H.; Loo, J. K.; Crawley, M. H.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Pharmacological inhibition of KIT activates MET signaling in gastrointestinal stromal tumors
    Journal Article

    Cohen, N. A.; Zeng, S.; Seifert, A. M.; Kim, T. S.; Sorenson, E. C.; Greer, J. B.; Beckman, M. J.; Santamaria-Barria, J. A.; Crawley, M. H.; Green, B. L.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth
    Journal Article

    Ran, L.; Sirota, I.; Cao, Z.; Murphy, D.; Shukla, S.; Xie, Y.; Kaufmann, M. C.; Gao, D.; Zhu, S.; Rossi, F.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • Dual lineage inhibition of ETV1 and KIT disrupts the ETV1-KIT feed forward circuit and potentiates imatinib antitumor effect in GIST oncogenesis
    Meeting Abstract

    Ran, L.; Sirota, I.; Cao, Z.; Murphy, D.; Shukla, S.; Rossi, F.; Wongvipat, J.; Tap, W. D.; Besmer, P.; Antonescu, C. R.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor
    Journal Article

    Kim, T. S.; Cavnar, M. J.; Cohen, N. A.; Sorenson, E. C.; Greer, J. B.; Seifert, A. M.; Crawley, M. H.; Green, B. L.; Popow, R.; Pillarsetty, N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save